Transport of biomolecules to the brain and the role of tanycytes of the ME/ARH

DRA symposium

The recent success in therapeutic regulation of metabolism by compounds such as GLP-1 analogues, has demonstrated that it actually is possible to get larger biomolecules into the brain. The symposium will deal with how biomolecules such as peptides, antibodies and peptidomimetics may enter the brain, as well as the effects of therapeutic compounds on obesity and the role of the tanycytes of the median eminence in the transport of compounds such as GLP-1, to their targets.

Programme

13:30 Introduction
Birger Brodin, Department of Pharmacy, University of Copenhagen, Denmark
13:45 Endocytosis and Transcytosis of antibodies/receptors in the vascular endothelium
Morten Schallburg Nielsen, Department of Biomedicine, Aarhus University, Denmark
14:15 Lipidized neuropeptides as potential tool for treatment of obesity, type 2 diabetes and neurodegeneration
Lenka Maletínská, Institute of Organic Chemistry and Biochemistry of the CAS, Praha, Czech Republic
14:45 Coffee break
15:00 Generating human arcuate nucleus tanycytes and neurons from stem cells
Zehra Caldwell, reNEW NNF Center for Stem Cell Medicine,  University of Copenhagen, Denmark
15:30 Advancing Peptide-Based Drug Discovery in Metabolic Diseases at Gubra: Insights from the industry
Anja Mosekjær Bengtsson, In Vitro and Pharmaceutical Research, Gubra Hørsholm, Denmark
16:00-16:05 Wrap up by Birger Brodin


The symposium is organized on behalf of the graduate programme in pharmaceutical sciences, Drug Research Academy, by Professor Birger Brodin Larsen, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen.

The symposium is free of charge and open for attendance by all interested parties. It is not necessary to pre-register.